Company Filing History:
3 out of 220 
1 out of 5,463 
1 out of 2,538 Years Active: 2003-2006
Title: Qingping Zeng: Innovator in Anticoagulant Therapy
Introduction
Qingping Zeng is a notable inventor based in Ballwin, MO (US), recognized for his contributions to the field of anticoagulant therapy. He holds a total of five patents, showcasing his innovative approach to medical science and drug development.
Latest Patents
Among his latest patents, Zeng has developed substituted polycyclic aryl and heteroaryl pyrazinones that are useful for the selective inhibition of the coagulation cascade. This invention relates to compounds that serve as inhibitors of serine proteases involved in the coagulation process. These compounds, compositions, and methods are aimed at providing effective anticoagulant therapy for the treatment and prevention of various thrombotic conditions, including coronary artery and cerebrovascular diseases.
Career Highlights
Zeng has had a distinguished career, working with prominent organizations such as Pharmacia Corporation and the University of Texas System. His experience in these institutions has significantly contributed to his expertise in the development of innovative therapeutic solutions.
Collaborations
Some of his notable coworkers include Michael S South and Melvin L Rueppel, who have collaborated with him on various projects throughout his career.
Conclusion
Qingping Zeng's work in the field of anticoagulant therapy exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to advancing healthcare solutions.